February 20, 2008 – Mobile Anesthesiologists Holdings LLC (Mobile) has announced the spin-off of its procurement operation into an independently operating company to be known as Pro Cure LLC, a company that will provide a full spectrum of procurement services to the rapidly growing ‘alternate-site’ market comprised of office-based practices as well as smaller chain and independent ASCs.

The alternate site market is the fastest growing segment in healthcare as an increasing number of surgical and diagnostic procedures are being migrated from hospitals, said the company. According to the SMG Group, in 2007 25 percent of all surgical/diagnostic procedures were performed in the office-based setting and it is projected that over 50 percent of all procedures will be migrated by 2010. Fueling this exponential growth is the fact that the delivery of medical care at alternate sites, specifically ambulatory surgery centers and physicians offices is as safe or safer than the hospital setting but significantly less expensive, according to the company.

Pro Cure has reportedly built its business model around this cost disparity. Pro Cure aims to provider independent healthcare provider organizations the same benefit from the pricing advantages enjoyed by hospitals and corporate chains.

In late 2007, Mobile began offering its internal procurement resources to outside clients saving them as much as 60 percent on anesthesia specific drugs and up to 30 percent on average on their overall procurement portfolio, said the company.

On Feb. 19, Pro Cure, officially started to operate independently of Mobile Anesthesiologists with Scott C. Mayer as president and Richard J. Harris as executive chairman.

For more information: www.pro-curemed.com


Related Content

News | Pediatric Imaging

April 10, 2025 — Cincinnati Children’s and GE HealthCare will form a strategic research program focused on driving ...

Time April 10, 2025
arrow
News | Radiology Imaging

Jan. 15, 2025 — University of California, San Francisco (UCSF) Department of Radiology & Biomedical Imaging and GE ...

Time January 27, 2025
arrow
News | Contrast Media

Jan. 10, 2025 – Bayer has announced positive topline results of the Phase III QUANTI studies evaluating the efficacy and ...

Time January 14, 2025
arrow
News | Women's Health

Aug. 19, 2024 — GE HealthCare recently announced a collaboration with the University of California San Diego School of ...

Time August 29, 2024
arrow
News | Radiology Business

July 25, 2024 — Immunis, Inc., a clinical-stage biotech developing groundbreaking secretome therapeutics for age and ...

Time July 25, 2024
arrow
News | RSNA

July 23, 2024 — Professional registration is open for RSNA 2024, the world’s largest radiology forum. This year’s theme ...

Time July 23, 2024
arrow
News | Artificial Intelligence

July 23, 2024 — Researchers at the National Institutes of Health (NIH) found that an artificial intelligence (AI) model ...

Time July 23, 2024
arrow
News | Artificial Intelligence

July 17, 2024 — Hyperfine, a groundbreaking medical device company that has redefined brain imaging with the world’s ...

Time July 17, 2024
arrow
News | Prostate Cancer

July 11, 2024 — GE HealthCare’s MIM Software, a global provider of medical imaging analysis and artificial intelligence ...

Time July 11, 2024
arrow
News | Prostate Cancer

July 2, 2024 — A new editorial paper was published in Oncoscience (Volume 11) on May 20, 2024, entitled, “Deep learning ...

Time July 02, 2024
arrow
Subscribe Now